skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Oxford University Press:Jisc Collections:Medicine Collection:2018 remover tipo de recurso: Outros remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation
Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation
Material Type:
Outros 		Adicionar ao Meu Espaço

Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation

Wolf, J ; Heist, R ; Kim, TM ; Nishio, M ; Dooms, C ; Kanthala, RR ; Leo, E ; Giorgetti, E ; Wang, Y ; Mardjuadi, FI ; Cortot, A

ANNALS OF ONCOLOGY, 2022, Vol.33 (7), p.S1007-S1008

ELSEVIER

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.